|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/12 | |
| C07D 239/94 | |||
| A61K 31/517 | |||
| A61P 31/18 |
| (11) | Number of the document | 3237398 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15832711.4 |
| Date of filing the European patent application | 2015-12-23 | |
| (97) | Date of publication of the European application | 2017-11-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/000460 |
| Date | 2015-12-23 |
| (87) | Number | WO 2016/105564 |
| Date | 2016-06-30 |
| (30) | Number | Date | Country code |
| 201462096748 P | 2014-12-24 | US |
| (72) |
JANSA, Petr, US
SIMON, Petr, CZ
LANSDON, Eric, US
HU, Yunfeng, Eric, US
BASZCZYNSKI, Ondrej, CZ
DEJMEK, Milan, CZ
MACKMAN, Richard, L., US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
Institute of Organic Chemistry and Biochemistry AS CR, V.V.I., Flemingovo nam. 2, 16610 Praha 6, CZ |
| (54) | QUINAZOLINE DERIVATIVES USED TO TREAT HIV |
| QUINAZOLINE DERIVATIVES USED TO TREAT HIV |